A detailed history of Riverview Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Riverview Trust CO holds 260 shares of AZN stock, worth $16,754. This represents 0.02% of its overall portfolio holdings.

Number of Shares
260
Holding current value
$16,754
% of portfolio
0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$76.67 - $87.62 $19,934 - $22,781
260 New
260 $20,000
Q2 2019

Jul 12, 2019

SELL
$37.28 - $41.68 $4,175 - $4,668
-112 Closed
0 $0
Q1 2019

Apr 10, 2019

BUY
$35.49 - $43.02 $3,974 - $4,818
112 New
112 $5,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Riverview Trust CO Portfolio

Follow Riverview Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Riverview Trust CO with notifications on news.